from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3386/-

LFCtreatmentdescriptionclass of inhibitor

-0.294

Amikacinug/mL Amikacintranslation

-0.288

Cap5-10ug/mL Capreomycintranslation

0.059

Rox10-50 ug/mL Roxithromycintranslation

0.089

SM2-5 ug/mL Streptomycintranslation

-0.725

Tet5-10 ug/mL Tetracyclinetranslation

-0.021

Rif0.2-5ug/mL Rifampicintranscription

-1.453

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.910

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.114

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.419

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.150

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.852

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.094

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.071

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.758

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-1.252

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.036

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.317

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.941

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.007

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.530

KCN5-20 ug/mL Potassium cyaniderespiration

-0.528

NaN30.2-2 mM Sodium aziderespiration

-0.940

Nigericin50 uM Nigericinrespiration

0.424

TRC10-150 ug/mL Triclosanrespiration

0.052

TRZ10-25 ug/mL Thioridazinerespiration

-0.665

Valinomycin0.5-10 uM Valinomycinrespiration

-1.914

ZnSO42 mM ZnSO4respiration

-0.139

menadione6-10 ug/mL Menadionerespiration

-0.228

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.495

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.144

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.149

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.629

NRP_1Non-replicating persistence stage 1dosRassociated

0.353

Amp0.2mg/mL AmpicillincellWall

0.049

Cephalexin20-100 ug/mL CephalexincellWall

-0.800

Cerulenin0.32-5 ug/mL CerulenincellWall

0.713

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.130

EMB10-20 ug/mL EthambutolcellWall

-0.039

Eta12-40 ug/mL EthionamidecellWall

-0.421

INH0.2-0.4 ug/mL IsoniazidcellWall

0.234

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.118

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.419

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.722

BZA0.12 mg/mL BenzamidearomaticAmides

0.816

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.318

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.950

H2O24 mM hydrogen peroxideDNAdamaging

-1.489

Levo10 ug/mL LevofloxacinDNAdamaging

0.913

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.317

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.288

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.059

UVUV-irradiationDNAdamaging

0.592

ARP41-4 ug/mL Antitubercular compound ARP4?

0.178

Antimycin12.5-50 ug/mL Antimycin A?

-0.804

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.576

PA_110-50 ug/mL Antitubercular compound PA-1?

0.757

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.126

PA8240.2-2 ug/mL PA-824?

0.443

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.459

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.657

Verapamil50 uM Verapamil?

-0.797

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.465

methoxatin10-20 ug/mL Methoxatin?